Portal Hypertension in Liver Cirrhosis and Drug Therapy
Portal Hypertension in Liver Cirrhosis and Drug Therapy
批准号:
01570411
负责人:
OHNISHI Akihiro
金额:
$0.64万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1991
中文摘要
由于肝硬变患者的肾素和血管紧张素水平升高,因此研究血管紧张素转换酶(ACE)抑制剂对门脉血流动力学的影响是合乎逻辑的。此外,有证据表明某些前列腺素(PG)可能参与调节肝脏阻力,甚至可能参与维持高动力状态,因此有必要更多地研究PG对肝脏和门脉血流动力学的影响。由于对上述问题的研究很少,我们开始从动物模型和肝硬变患者的体循环(S)和门脉(P)血液循环中研究肾素、血管紧张素II、儿茶酚胺和前列腺素的水平。在两种实验动物模型(CCl_4诱导的肝硬变大鼠(LC大鼠)和部分结扎2周的门脉高压大鼠(PH大鼠))和对照组(C)大鼠中,我们测定了稳定的PG代谢产物6-酮-前列腺素F_1α和6-酮-前列腺素(6KPG)从…用兔抗体放射免疫法测定血栓素B_2(TXB_2)。LC大鼠(S,2008;正负GT;549 pg/ml;P,4802;正负GT;654 pg/ml)TGE-S和P循环中6KPG浓度约为C大鼠(S,1116;正负GT;186 pg/ml;P 983<;正负GT;177 pg/ml)的2倍和5倍。门静脉组织6KPG在LC组和PH组显著高于C组(分别为255、415、43、142pg/mgWW)。LC大鼠(S,3059;正负GT;1309pg/ml;P,2315;正负GT;633pg/ml)血浆S和P-TXB_2浓度均高于PH大鼠(S,1243(±)Sy.(178pg/ml;P,未获得)和C大鼠(S,343()Sy.+-.[)63pg/ml;P,417(]Sy.+.[)65pg/ml]。模型组大鼠组织TXB_2水平与C组大鼠无明显差异。在临床研究中,我们采集了11例肝硬变患者的PG血样。6P循环的KPG和TXB_2水平显著高于S循环的10倍和14倍:P分别为57、31和484,P分别为192pg/ml、4pg/ml和8pg/ml。这些结果表明,PG的产生,特别是PGI_2,在肝硬变的门脉循环中被刺激,并可能参与门脉内压力的升高。在第二步,我们研究了ACE抑制剂依那普利对10例肝硬变患者的肾脏影响。依那普利10 mg口服,疗程8d。因此,我们观察到依那普利具有良好的临床肾脏效应,即它显著增加内生肌酐清除量,并产生大量的钠尿。提示血管紧张素转换酶抑制剂依那普利可能是治疗肝硬变合并周围水肿和腹水的工具之一。较少
英文摘要
Because renin and angiotensin levels are increased in patients with liver eirrhosis, it could be logical to investigate the effects of angiotensin converting enzyme(ACE)inhibitors on portal hemodynamics. Additionaly, given the evidences that some prostaglandin(PG)may be involved in regulation of hepatic resistance and perhaps even in maintenance of the hyperdynamic state, more studies of PG effects on hepatic and portal hemodynamics are warranted.Because of few studies investigated the above these issues, we started to investigate the renin, angiotensin II, catecholamines, and prostanoids levels both in systemic (S) and portal (P) blood circulations from animal models and the patients with liver cirrhosis. In two experimetal animal models (the rats with CCl_4-induced liver cirrhosis (LC rat) and the rats with portal hypertension induced by 2 weeks partial ligation (PH rat)) and control (C) rats, we measured the stable PG metabolites 6-keto-prostagiandin F_<1alpha> (6KPG), from PGI_2, a … More nd thromboxane B_2 (TXB_2), from TXA_2 by radioimmunoassay employing rabbit-antibody. The 6KPG concentrations in tge S and P circulations were approximately 2 and 5 times higher (p<0.05) in LC rats(S, 2008 <plus-minus>549 pg/ml ; P, 4802<plus-minus>654 pg/ml) than in C rats (S, 1116<plus-minus>186 pg/ml ; P 983<plus-minus>177 pg/ml (mean<plus-minus>SE)). The tissue 6KPG of the portal vein was significantly higher in LC and PH rats than in C rats (255<plus-minus>36, 415<plus-minus>43, 142<plus-minus>23 pg/mgWW, respectively). The S and P TXB_2 concentrations were higher in LC rats(S, 3059<plus-minus>1309 pg/ml ; P, 2315<plus-minus>633 pg/ml) than in PH-rats (S, 1243(]SY.+-. (]178 pg/ml ; P, not obtained) and C rats (S, 343(]SY.+-.[)63 pg/ml ; P, 417(]SY.+-.[)65 pg/ml). The tissue TXB_2 levels did not differ between the model rats and the C rats. In the clinical study, we collected the PG's blood samples from 11 cirrhotic patients. 6KPG and TXB_2 levels in the P circulation were significantly (p<0.01) higher than (10 and 14 times) those in the S circulation : 57(]SY.+-.[)31 and 484(]SY.+-.[)192 pg/ml in P, 4(]SY.+-.[)1 and 50(]SY.+-.[)8 pg/ml in S, respectively. These results indicated that production of PG, particularly PGI_2, is stimulated in the portal circulation in liver cirrhosis and could be involved in the elevation of intraportal pressure.In the second step, we investigated the renal effects of an ACE inhibitor, enalapril in ten patients with liver cirrhosis. Enalapril was administered orally at the dose of 10 mg for eight days. As a result we observed clinically favorable renal effects of enalapril, that is, it increased creatinine clearance markedly and produced considerable natriuresis. This results suggested that enalapril, a ACE inhibitor, may be one of tools for the treatment of cirrhotic condition complicated with peripheral edema and ascites. Less
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ohnishi,A.: "Intrapatient comparison of acute hemodynamic,hormonal and natriuretic responses to captopril versus enalapril in liver cirrhosis." Clinical Pharmacology & Therapeutics. 48. 67-75 (1990)
Ohnishi,A.:“肝硬化患者对卡托普利与依那普利的急性血流动力学、激素和利尿钠反应的内部比较。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ohnishi,A.: "Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation,catecholamine concentration and platelet aggregation in humans." Clinical Pharmacology & Therapeutics. 51. (1992)
Ohnishi,A.:“持续抑制血栓素合酶对运动引起的人体类二十烷酸形成、儿茶酚胺浓度和血小板聚集变化的影响。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Akihiro Ohnishi: "Intrapatient comparison of acute hemodynamic, hormonal and natriuretic responses to captopril versus enalapril in liver cirrhosis" Clin. Pharmacol. Ther.48. 67-75 (1990)
Akihiro Ohnishi:“肝硬化患者对卡托普利与依那普利的急性血流动力学、激素和利尿钠反应的内部比较”Clin。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
大野 俊幸: "肝疾患とアンギオテンシン変換酵素(ACE)活性の変動" 肝臓. 32. 266-273 (1991)
Toshiyuki Ohno:“肝脏疾病和血管紧张素转换酶 (ACE) 活性的变化”肝脏。 32. 266-273 (1991)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Akihiro Ohnishi: "Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration and platelet aggregation in humans" Clin. Pharmacol. Ther.51. (1992)
Akihiro Ohnishi:“持续抑制血栓素合酶对运动引起的人体类二十烷酸形成、儿茶酚胺浓度和血小板聚集变化的影响”Clin。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 24 条
Genetic polymorphism in the cytochrome P450-2C19 genes in Japanese patients with hepatocellu-lar carcinoma and hepatitis C infection
-
批准号:08670629
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1996
-
负责人:OHNISHI Akihiro
-
依托单位:
海外基金